Features of Cardiac Remodeling, Associated With Blood Pressure and Fibrosis Biomarkers, Are Frequent in Subjects With Abdominal Obesity-Reference-Cited by-同舟云学术

Features of Cardiac Remodeling, Associated With Blood Pressure and Fibrosis Biomarkers, Are Frequent in Subjects With Abdominal Obesity

Published:2014-04 Issue:4 Volume:63 Page:740-746
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Eschalier Romain¹,Rossignol Patrick¹,Kearney-Schwartz Anna¹,Adamopoulos Chris¹,Karatzidou Kyparissi¹,Fay Renaud¹,Mandry Damien¹,Marie Pierre-Y.¹,Zannad Faïez¹

Affiliation:

1. From the INSERM, Center d’Investigation Clinique CIC-P 9501, Nancy, France (R.E., P.R., A.K.S., C.A., K.K., R.F., F.Z.); CHU-Nancy, Department of Cardiology, Nancy, France (F.Z.); Université de Lorraine, Nancy, France (P.R., D.M., P.Y.M., F.Z.); INSERM, U1116, Nancy, France (P.R., P.Y.M., F.Z.); Clermont Université, Université d’Auvergne, UMR6284, Clermont-Ferrand, France (R.E.); CHU Clermont-Ferrand, Department of Cardiology, Clermont-Ferrand, France (R.E.); CHU-Nancy, Department of Radiology,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference39 articles.

1. Joint Effects of Physical Activity, Body Mass Index, Waist Circumference, and Waist-to-Hip Ratio on the Risk of Heart Failure

2. News and Views

3. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

4. Obesity and the Risk of Heart Failure

5. The Dynamic Interaction Between Matrix Metalloproteinase Activity and Adverse Myocardial Remodeling

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Matrix Abnormalities Contribute to Cardiac Insulin Resistance and Associated Dysfunction in Diet-induced Obese Mice;2023-11-16

2. Causal effect of central obesity on left ventricular structure and function in preserved EF population: A Mendelian randomization study;Frontiers in Cardiovascular Medicine;2023-01-09

3. Tabersonine alleviates obesity‐induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1‐mediated inflammation;Phytotherapy Research;2022-11-24

4. The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism;Molecular and Cellular Biochemistry;2022-10-10

5. Cardiac and respiratory muscle responses to dietary N ‐acetylcysteine in rats consuming a high‐saturated fat, high‐sucrose diet;Experimental Physiology;2022-08-27